You are here

immunotherapy

Tactiva Therapeutics — A Biotech Startup Focusing on the Future of Immunotherapy

Tactiva Therapeutics — A Biotech Startup Focusing on the Future of Immunotherapy

Persimmon Development

Tactiva Therapeutics

Flag link:

In a small study, a cancer vaccine assist beats immunotherapy drugs alone

In a small study, a cancer vaccine assist beats immunotherapy drugs alone

Stat

cancer vaccines

Neon Therapeutics

metastatic non-small-cell lung cancer

metastatic bladder cancer

Flag link:

Are Natural Killer Cells the Next Big Thing in Immunotherapy?

Are Natural Killer Cells the Next Big Thing in Immunotherapy?

Motley Fool

NK immunotherapies

Flag link:

Provention’s Teplizumab Can Delay Onset of Type 1 Diabetes, Trial Results Show

Provention’s Teplizumab Can Delay Onset of Type 1 Diabetes, Trial Results Show

BioSpace

clinical trials

type 1 diabetes

Flag link:

ASCO 2019: The Long Game, Targeted Pills, First-Ever Buzz & More

ASCO 2019: The Long Game, Targeted Pills, First-Ever Buzz & More

Xconomy

Moderna Therapeutics

Nektar Therapeutics

Blueprint Medicines

Flag link:

The entrepreneur behind the cancer immunotherapy revolution

The entrepreneur behind the cancer immunotherapy revolution

Stat

Flag link:

Merck to buy immunotherapy developer Immune Design for $300 million

Merck to buy immunotherapy developer Immune Design for $300 million

Reuters

Flag link:

After Tesaro buy, GSK wades deeper into cancer unveiling big immunotherapy deal with Germany's Merck

After Tesaro buy, GSK wades deeper into cancer unveiling big immunotherapy deal with Germany's Merck

Endpoints

Flag link:

Five Things To Look Out For In Cancer Research In 2019

Five Things To Look Out For In Cancer Research In 2019

Forbes

Flag link:

Not So Fast With Immune Therapy For Breast Cancer

Not So Fast With Immune Therapy For Breast Cancer

Forbes

Flag link:

CytoReason: Machine-Learning Findings Reveal New Information That Might Lead to Improved Immunotherapy for Refractory Melanoma Patients

CytoReason: Machine-Learning Findings Reveal New Information That Might Lead to Improved Immunotherapy for Refractory Melanoma Patients

CP Wire

machine learning

Flag link:

CytoReason: Machine-Learning Findings Reveal New Information That Might Lead to Improved Immunotherapy for Refractory Melanoma Patients

Flag link:

T-cell therapy for eradicating HIV reservoirs proves safe in small study

T-cell therapy for eradicating HIV reservoirs proves safe in small study

Fierce Biotech

Flag link:

Sanofi says on track to regain solid position in cancer drugs

Sanofi says on track to regain solid position in cancer drugs

Reuters

molecular oncology

Flag link:

Advaxis Doses First Patient With Customized Immunotherapy Targeting Personal Neoantigens

Advaxis Doses First Patient With Customized Immunotherapy Targeting Personal Neoantigens

CP Wire

non-small cell lung cancer

clinical trials

Flag link:

Advaxis Doses First Patient With Customized Immunotherapy Targeting Personal Neoantigens

Flag link:

Advaxis cuts staff as it seeks partner for troubled cancer vaccine

Advaxis cuts staff as it seeks partner for troubled cancer vaccine

Fierce Biotech

axalimogene filolisbac

cancer vaccines

Flag link:

A new cancer care dilemma: Patients want immunotherapy even when evidence is lacking

A new cancer care dilemma: Patients want immunotherapy even when evidence is lacking

Stat

Flag link:

FDA Accepts Turnstone Biologics' IND for Immunotherapy Targeting HPV Positive Cancers

FDA Accepts Turnstone Biologics' IND for Immunotherapy Targeting HPV Positive Cancers

CP Wire

Turnstone Biologics

Flag link:

FDA Accepts Turnstone Biologics' IND for Immunotherapy Targeting HPV Positive Cancers

Turnstone Biologics

Flag link:

Pages